History of Novartis
Novartis is a global healthcare company based in Switzerland, established in 1996 through the merger of two major pharmaceutical companies: Ciba-Geigy and Sandoz. Ciba-Geigy had roots dating back to the early 19th century, known for its innovations in chemicals and pharmaceuticals, while Sandoz, founded in 1886, focused on developing medicines. The merger of these two companies created Novartis, a leader in the pharmaceutical industry, with a diverse portfolio spanning innovative medicines, generics, and eye care.
Since its formation, Novartis has consistently expanded its reach through strategic acquisitions and investments in research and development. In 2006, the company acquired Chiron, a biotechnology firm, enhancing its capabilities in immunology, oncology, and vaccines. Novartis also ventured into the ophthalmology sector with the purchase of Alcon, a company specializing in eye care. With a strong commitment to addressing global health challenges, Novartis has contributed significantly to the development of treatments for cancer, cardiovascular diseases, and other major health conditions.
Today, Novartis continues to focus on improving patient outcomes through innovation and cutting-edge technology. The company is committed to advancing medical science with a strong emphasis on personalized medicine, digital health, and gene therapy. With operations in over 140 countries, Novartis remains a prominent player in the global healthcare landscape, shaping the future of medicine with groundbreaking therapies.